Artivion, Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Artivion, Inc. filed 64 open-market sales worth $20.7 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Green Andrew M, SVP, Regulatory and Quality, sold 11,480 shares at $24.97 on 10 September 2026, filed 11 September 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 10 September 2026 | Green Andrew M | SVP, Regulatory and Quality | Sale | 11,480 | $24.97 | $286,656 | Form 4 |
| 3 September 2026 | Green Andrew M | SVP, Regulatory and Quality | Sale | 1,493 | $26.02 | $38,842 | Form 4 |
| 2 September 2026 | Green Andrew M | SVP, Regulatory and Quality | Sale | 6,510 | $27.27 | $177,495 | Form 4 |
| 19 August 2026 | Mackin James P | President & CEO | Sale | 70,000 | $28.95 | $2.0 million | Form 4 |
| 14 August 2026 | Green Andrew M | SVP, Regulatory and Quality | Sale | 616 | $28.55 | $17,586 | Form 4 |
| 14 August 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Sale | 715 | $28.55 | $20,413 | Form 4 |
| 12 August 2026 | Holloway Jean F | SVP, General Counsel | Sale | 977 | $28.49 | $27,835 | Form 4 |
| 11 June 2026 | Green Andrew M | SVP, Regulatory and Quality | Sale | 14,001 | $20.71 | $289,919 | Form 4 |
| 11 June 2026 | Green Andrew M | SVP, Regulatory and Quality | Sale | 30,000 | $20.69 | $620,820 | Form 4 |
| 4 March 2026 | Holloway Jean F | SVP, General Counsel | Sale | 8,962 | $38.00 | $340,556 | Form 4 |
| 3 March 2026 | Horton Amy | VP, Chief Accounting Officer | Sale | 901 | $37.78 | $34,036 | Form 4 |
| 3 March 2026 | Holloway Jean F | SVP, General Counsel | Sale | 3,843 | $37.78 | $145,172 | Form 4 |
| 3 March 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2,149 | $37.78 | $81,180 | Form 4 |
| 3 March 2026 | Davis John E | Chief Commercial Officer | Sale | 4,573 | $37.78 | $172,748 | Form 4 |
| 3 March 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Sale | 6,316 | $37.78 | $238,591 | Form 4 |
| 3 March 2026 | Mackin James P | President & CEO | Sale | 17,887 | $37.78 | $675,692 | Form 4 |
| 2 March 2026 | Horton Amy | VP, Chief Accounting Officer | Sale | 641 | $38.02 | $24,374 | Form 4 |
| 2 March 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 1,513 | $38.02 | $57,532 | Form 4 |
| 2 March 2026 | Mackin James P | President & CEO | Sale | 14,911 | $38.02 | $566,989 | Form 4 |
| 2 March 2026 | Holloway Jean F | SVP, General Counsel | Sale | 2,183 | $38.02 | $83,008 | Form 4 |
| 2 March 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Sale | 5,178 | $38.02 | $196,893 | Form 4 |
| 2 March 2026 | Davis John E | Chief Commercial Officer | Sale | 2,784 | $38.02 | $105,861 | Form 4 |
| 24 February 2026 | Horton Amy | VP, Chief Accounting Officer | Sale | 830 | $35.69 | $29,625 | Form 4 |
| 24 February 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 1,259 | $35.69 | $44,937 | Form 4 |
| 24 February 2026 | Holloway Jean F | SVP, General Counsel | Sale | 1,668 | $35.69 | $59,536 | Form 4 |
| 24 February 2026 | Mackin James P | President & CEO | Sale | 13,936 | $35.69 | $497,418 | Form 4 |
| 24 February 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Sale | 4,485 | $35.69 | $160,083 | Form 4 |
| 24 February 2026 | Davis John E | Chief Commercial Officer | Sale | 2,075 | $35.69 | $74,063 | Form 4 |
| 23 February 2026 | Horton Amy | VP, Chief Accounting Officer | Sale | 1,731 | $37.59 | $65,065 | Form 4 |
| 23 February 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2,423 | $37.59 | $91,076 | Form 4 |
| 23 February 2026 | Holloway Jean F | SVP, General Counsel | Sale | 3,079 | $37.59 | $115,733 | Form 4 |
| 23 February 2026 | Mackin James P | President & CEO | Sale | 20,962 | $37.59 | $787,920 | Form 4 |
| 23 February 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Sale | 4,981 | $37.59 | $187,226 | Form 4 |
| 23 February 2026 | Davis John E | Chief Commercial Officer | Sale | 3,773 | $37.59 | $141,820 | Form 4 |
| 15 December 2025 | Davis John E | Chief Commercial Officer | Sale | 5,000 | $45.11 | $225,550 | Form 4 |
| 8 December 2025 | Horton Amy | VP, Chief Accounting Officer | Sale | 4,572 | $44.42 | $203,084 | Form 4 |
| 3 December 2025 | Mackin James P | President & CEO | Sale | 30,921 | $45.46 | $1.4 million | Form 4 |
| 3 December 2025 | Holloway Jean F | SVP, General Counsel | Sale | 2,048 | $45.30 | $92,774 | Form 4 |
| 3 December 2025 | Holloway Jean F | SVP, General Counsel | Sale | 5,267 | $45.30 | $238,595 | Form 4 |
| 2 December 2025 | Mackin James P | President & CEO | Sale | 30,921 | $45.56 | $1.4 million | Form 4 |
| 21 November 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 14,586 | $44.92 | $655,189 | Form 4 |
| 21 November 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 5,715 | $45.35 | $259,152 | Form 4 |
| 21 November 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 18,705 | $44.91 | $840,042 | Form 4 |
| 21 November 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 8,370 | $45.34 | $379,538 | Form 4 |
| 20 November 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 11,888 | $44.14 | $524,736 | Form 4 |
| 20 November 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2,033 | $44.31 | $90,092 | Form 4 |
| 20 November 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 1,355 | $44.28 | $59,997 | Form 4 |
| 18 November 2025 | Hoff Elizabeth A | Director | Sale | 4,200 | $45.10 | $189,412 | Form 4 |
| 17 November 2025 | Holloway Jean F | SVP, General Counsel | Sale | 6,394 | $45.17 | $288,817 | Form 4 |
| 17 November 2025 | Davis John E | Chief Commercial Officer | Sale | 6,394 | $45.17 | $288,817 | Form 4 |
| 17 November 2025 | Horton Amy | VP, Chief Accounting Officer | Sale | 6,000 | $45.73 | $274,380 | Form 4 |
| 14 November 2025 | Holloway Jean F | SVP, General Counsel | Sale | 6,393 | $45.00 | $287,685 | Form 4 |
| 14 November 2025 | Davis John E | Chief Commercial Officer | Sale | 6,393 | $44.67 | $285,575 | Form 4 |
| 13 November 2025 | Horton Amy | VP, Chief Accounting Officer | Sale | 3,482 | $45.86 | $159,678 | Form 4 |
| 13 November 2025 | Davis John E | Chief Commercial Officer | Sale | 6,563 | $45.86 | $300,966 | Form 4 |
| 13 November 2025 | Mackin James P | President & CEO | Sale | 34,210 | $45.86 | $1.6 million | Form 4 |
| 13 November 2025 | Holloway Jean F | SVP, General Counsel | Sale | 5,761 | $45.86 | $264,188 | Form 4 |
| 13 November 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 4,993 | $45.86 | $228,969 | Form 4 |
| 11 November 2025 | Holloway Jean F | SVP, General Counsel | Sale | 10,000 | $46.18 | $461,800 | Form 4 |
| 10 November 2025 | Holloway Jean F | SVP, General Counsel | Sale | 2,960 | $44.62 | $132,072 | Form 4 |
| 10 November 2025 | Mackin James P | President & CEO | Sale | 17,580 | $44.62 | $784,402 | Form 4 |
| 10 November 2025 | Davis John E | Chief Commercial Officer | Sale | 3,373 | $44.62 | $150,500 | Form 4 |
| 10 November 2025 | Horton Amy | VP, Chief Accounting Officer | Sale | 1,789 | $44.62 | $79,823 | Form 4 |
| 10 November 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2,566 | $44.62 | $114,492 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Artivion, Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.